Status:
UNKNOWN
Anesthesia on Gut Microbiota and Metabolomics
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Hepatic Tumor Resection
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
Hepatectomies are performed for the treatment of hepatic tumors and livingdonor liver transplantation. The success of liver resection relies on the remnant liver's ability to regenerate after major ti...
Eligibility Criteria
Inclusion
- Expected to receive hepatic tumor resection in National Taiwan University Hospital, age between 20 and 75 years old.
Exclusion
- Previous use of antibiotics within four weeks.
- Previous gastrointestinal surgery.
Key Trial Info
Start Date :
February 20 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04767503
Start Date
February 20 2021
End Date
December 31 2022
Last Update
March 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology
Taipei, Taiwan, 100